Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J, Peeters T
Department of Gastroenterology, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.
Gut. 2006 Mar;55(3):327-33. doi: 10.1136/gut.2004.060426. Epub 2005 Oct 10.
Recent studies in animals have shown that ghrelin stimulates upper gastrointestinal motility through the vagus and enteric nervous system. The aim of the present study therefore was to simultaneously investigate the effect of administration of ghrelin on upper gastrointestinal motility and to elucidate its mode of action by measuring plasma levels of gastrointestinal hormones in humans.
Nine healthy volunteers (four males; aged 22-35 years) underwent combined antroduodenal manometry and proximal stomach barostat study on two separate occasions at least one week apart. Twenty minutes after the occurrence of phase III of the migrating motor complex (MMC), saline or ghrelin 40 mug was administered intravenously over 30 minutes in a double blind, randomised, crossover fashion. Ghrelin, motilin, pancreatic polypeptide, glucagon, and somatostatin were measured by radioimmunoassay in blood samples obtained at 15-30 minute intervals. The influence of ghrelin or saline on MMC phases, hormone levels, and intraballoon volume was compared using paired t test, ANOVA, and chi(2) testing.
Spontaneous phase III occurred in all subjects, with a gastric origin in four. Administration of ghrelin induced a premature phase III (12 (3) minutes, p<0.001; gastric origin in nine, p<0.05), compared with saline (95 (13) minutes, gastric origin in two). Intraballoon volumes before infusion were similar (135 (13) v 119 (13) ml; NS) but ghrelin induced a longlasting decrease in intraballoon volume (184 (31) v 126 (21) ml in the first 60 minutes; p<0.05). Administration of ghrelin increased plasma levels of pancreatic polypeptide and ghrelin but motilin, somatostatin, and glucagon levels were not altered.
In humans, administration of ghrelin induces a premature gastric phase III of the MMC, which is not mediated through release of motilin. This is accompanied by prolonged increased tone of the proximal stomach.
近期动物研究表明,胃饥饿素通过迷走神经和肠神经系统刺激上消化道运动。因此,本研究的目的是同时研究胃饥饿素给药对上消化道运动的影响,并通过测量人体胃肠道激素的血浆水平来阐明其作用方式。
9名健康志愿者(4名男性;年龄22 - 35岁)在至少相隔一周的两个不同时间接受了联合十二指肠测压和近端胃恒压器研究。在移行性运动复合波(MMC)的III期出现20分钟后,以双盲、随机、交叉方式在30分钟内静脉注射生理盐水或40微克胃饥饿素。每隔15 - 30分钟采集血样,通过放射免疫分析法测定胃饥饿素、胃动素、胰多肽、胰高血糖素和生长抑素。使用配对t检验、方差分析和卡方检验比较胃饥饿素或生理盐水对MMC各期、激素水平和球囊内体积的影响。
所有受试者均出现自发性III期,其中4例起源于胃。与生理盐水(95(13)分钟,2例起源于胃)相比,注射胃饥饿素可诱导过早出现III期(12(3)分钟,p<0.001;9例起源于胃,p<0.05)。输注前球囊内体积相似(135(13)对119(13)毫升;无显著性差异),但胃饥饿素可导致球囊内体积持续下降(前60分钟内184(31)对126(21)毫升;p<0.05)。注射胃饥饿素可使血浆胰多肽和胃饥饿素水平升高,但胃动素、生长抑素和胰高血糖素水平未改变。
在人体中,注射胃饥饿素可诱导MMC过早出现胃III期,这并非通过胃动素的释放介导。同时近端胃张力持续增加。